← Leaderboards
Dinja Oosterhoff
Intravacc B.V.
$6,442,433
Attributed
$6,442,433
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.7M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$6,442,433 · 2
By mechanism
N01$6,442,433 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Immunogenicity”
- Kevin Saunders · Duke University$18,106,404
- Jason Dickens · Duke University$12,259,409
- Elizabeth Norton · Tulane University Of Louisiana$11,100,490
- Warwick Britton · University Of Sydney$10,964,476
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Shaunna Shen · Duke University$7,747,008
Research focus
ImmunogenicityEfficacy TestingEmerging Communicable DiseasesFormulationAnimal ModelAdvanced DevelopmentCommunicable DiseasesContractsResponseSafetyStability TestingToxicologyDisease OutbreaksVaccine DevelopmentVaccinesEfficacy EvaluationManufactureNeisseria GonorrhoeaeBacterial Drug ResistanceGonorrheaEnterovirus 68Antibiotic ResistanceBacterial ResistanceBiodefense
Grant awards (4)
Advanced Development of a Vaccine for Acute Flaccid Myelitis Associated with Enterovirus D68$1,004,130
N01 · FY2025 · AI · contact PI
Advanced Development of Vaccine Candidates for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases$2,674,055
N01 · FY2024 · AI · contact PI
DEVELOPMENT OF AN INTRANASAL VACCINE AGAINST GONORRHEA$756,750
N01 · FY2023 · AI · contact PI
DEVELOPMENT OF AN INTRANASAL VACCINE AGAINST GONORRHEA$2,007,498
N01 · FY2022 · AI · contact PI